Market Overview

UPDATE: Sterne Agee Initiates Cerner at Neutral on Valuation

Share:
Related CERN
Benzinga's Top Upgrades
Barron's Picks And Pans: Interpublic, Zimmer Biomet And More
Healthcare ratings roundup - upgrades/downgrades (Seeking Alpha)

In a report published Wednesday, Sterne Agee analyst Greg T. Bolan initiated coverage on Cerner (NASDAQ: CERN) with a Neutral rating and $100.00 price target.

In the report, Sterne Agee noted, “At this point, we believe Cerner's bookings will grow at to slightly better than mid-teens growth in CY12. While impressive, we believe the current valuation of Cerner's stock reflects our optimistic outlook. Initiate coverage with a Neutral rating and $100 price target.”

Cerner closed on Tuesday at $98.14.

Latest Ratings for CERN

DateFirmActionFromTo
Jun 2016SunTrust Robinson HumphreyUpgradesNeutralBuy
Feb 2016Goldman SachsDowngradesBuyNeutral
Feb 2016Evercore ISI GroupDowngradesBuyHold

View More Analyst Ratings for CERN
View the Latest Analyst Ratings

Posted-In: Greg T. Bolan Sterne AgeeAnalyst Color Initiation Analyst Ratings

 

Related Articles (CERN)

View Comments and Join the Discussion!